Dyne Therapeutics (DYN) Shares Issued (2019 - 2026)
Dyne Therapeutics (DYN) posted quarterly Shares Issued of $13.4 million for Q2 2026, up 55.15% year-over-year from $8.6 million in Q2 2025, and up 7.05% quarter-over-quarter from $12.5 million in Q1 2026.
Dyne Therapeutics (DYN) Shares Issued (2019 - 2026) Analysis & Trends
Dyne Therapeutics (DYN) has reported Shares Issued for 8 consecutive years, with $13.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Shares Issued rose 55.15% year-over-year to $13.4 million; the TTM figure through Jun 2026 stood at $13.4 million (up 55.15% YoY), while the FY2025 annual figure was $9.9 million, up 14.16% from the prior year.
- Shares Issued rose to $13.4 million in Q2 2026 per DYN's latest filing, from $12.5 million in the prior quarter.
- Across five years, Shares Issued topped out at $13.4 million in Q2 2026 and bottomed at $7.7 million in Q3 2024.
- Historically, Shares Issued has averaged $9.3 million across 5 years, with a median of $9.0 million in 2023.
- Annual changes were most pronounced in 2024 — Shares Issued dropped 14.77% — and 2026, when it soared 55.15%.
- Dyne Therapeutics' Shares Issued stood at $9.4 million in 2022, then climbed by 5.68% to $9.9 million in 2023, then retreated by 12.44% to $8.7 million in 2024, then gained by 14.16% to $9.9 million in 2025, then soared by 35.29% to $13.4 million in 2026.
- Business Quant data shows DYN's Shares Issued at $13.4 million in Q2 2026, $12.5 million in Q1 2026, and $9.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Dyne Therapeutics | 4.26 Bn | 4.26 Bn | - | 13.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.41 Mn |
| Jun 30, 2026 | 13.41 Mn |
| Mar 31, 2026 | 12.52 Mn |
| Mar 31, 2026 | 12.52 Mn |
| Dec 31, 2025 | 9.91 Mn |
| Dec 31, 2025 | 9.91 Mn |
| Sep 30, 2025 | 9.65 Mn |
| Sep 30, 2025 | 9.65 Mn |
| Jun 30, 2025 | 8.64 Mn |
| Jun 30, 2025 | 8.64 Mn |
| Mar 31, 2025 | 8.83 Mn |
| Mar 31, 2025 | 8.83 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Dec 31, 2024 | 8.68 Mn |
| Sep 30, 2024 | 7.74 Mn |
| Sep 30, 2024 | 7.74 Mn |
| Jun 30, 2024 | 8.36 Mn |
| Jun 30, 2024 | 8.36 Mn |
| Mar 31, 2024 | 8.61 Mn |
| Mar 31, 2024 | 8.61 Mn |